79 related articles for article (PubMed ID: 1803776)
1. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
2. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
3. [The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis].
Grigorian SS; Pritsker AD; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):407-9. PubMed ID: 1803775
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
Naiman HB; Doyle AT; Ruben RJ; Kadish AS
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
[TBL] [Abstract][Full Text] [Related]
6. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study.
Stern Y; Felipovich A; Cotton RT; Segal K
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):169-71. PubMed ID: 17419519
[TBL] [Abstract][Full Text] [Related]
7. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
8. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
Thurmond LM; Brand CM; Leventhal BG; Finter NB; Johnston JM
J Lab Clin Med; 1991 Sep; 118(3):232-40. PubMed ID: 1919296
[TBL] [Abstract][Full Text] [Related]
9. [Antibodies to alpha-2A interferon in children with juvenile respiratory papillomatosis].
Kol'tsov VD; Onufrieva EK; Chireshkin DG; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1995; (5):24-6. PubMed ID: 7502448
[TBL] [Abstract][Full Text] [Related]
10. [Variants in the cytotoxic activity of natural killers against interferon-modified target cells].
Cheknëv SB; Narovlianskiĭ AN; Amchenkova AM; Sorokin AM
Dokl Akad Nauk SSSR; 1990; 315(5):1270-4. PubMed ID: 2088695
[No Abstract] [Full Text] [Related]
11. Evaluation of immunocompetency in juvenile laryngeal papillomatosis.
Perrick D; Wray BB; Leffell MS; Harmon JD; Porubsky ES
Ann Allergy; 1990 Jul; 65(1):69-72. PubMed ID: 2368934
[TBL] [Abstract][Full Text] [Related]
12. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
Garashchenko TI; Markova TP; Chuvirov DG
Vestn Otorinolaringol; 1996; (4):15-8. PubMed ID: 8966870
[TBL] [Abstract][Full Text] [Related]
13. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
Vacher S; Peytral C; Narcy P
Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions.
Kashima H; Leventhal B; Clark K; Cohen S; Dedo H; Donovan D; Fearon B; Gardiner L; Goepfert H; Lusk R
Laryngoscope; 1988 Mar; 98(3):334-40. PubMed ID: 3278186
[TBL] [Abstract][Full Text] [Related]
15. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758
[No Abstract] [Full Text] [Related]
16. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
Lotzová E; Savary CA; Gutterman JU; Quesada JR; Hersh EM
J Biol Response Mod; 1983; 2(5):482-96. PubMed ID: 6644351
[TBL] [Abstract][Full Text] [Related]
17. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
[TBL] [Abstract][Full Text] [Related]
18. [The detection of cytokine and immunoglobulin in sera of children with respiratory papillomatosis].
Xia Z; Yang Z; Guo Y; Wang Z; Xu Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 16(6):292-4. PubMed ID: 12599783
[TBL] [Abstract][Full Text] [Related]
19. Interferon enhanced natural killer function in Hodgkin's disease.
Levy S; Reins F; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM
Nouv Rev Fr Hematol (1978); 1986; 28(5):323-5. PubMed ID: 3808943
[TBL] [Abstract][Full Text] [Related]
20. [Natural killer activity in influenza patients].
Savitskiĭ GI; Grishchenko SV; Krylov VF; Kolobukhina LV; Kniazeva LD
Vopr Virusol; 1988; 33(3):290-2. PubMed ID: 3176429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
